What red light actually helps.

Wunsch and Matuschka (2014, Photomedicine and Laser Surgery 32(2): 93-100) ran two split-face RCTs totalling 113 subjects. After 30 sessions of red light therapy over 12 weeks, intradermal collagen density increased 45% versus baseline; skin roughness decreased 27%. Sham-controlled, blinded, objective measurement — not a marketing study.

The mechanism is fibroblast activation. Red light at 630–660nm penetrates to the dermis, activates cytochrome c oxidase in fibroblasts, ramps up Type I and Type III collagen synthesis, and simultaneously suppresses matrix metalloproteinases (the enzymes that break collagen down). Net effect: tilted balance toward collagen accumulation over months.

R1SE's bundled session delivers both red and near-infrared. Members targeting skin specifically benefit from 2–3 sessions per week for the first 12 weeks, then maintenance.

Stausholm et al. (2019, BMJ Open 9(10): e031142) meta-analysed 22 trials of red light therapy in knee osteoarthritis. At optimal doses (roughly 60 J/cm² over the joint), pain reduction averaged 70% versus placebo, with significant improvement in WOMAC function scores.

Mechanism: peripheral nerve modulation (slowing nociceptive signalling), reduced inflammatory cytokines (TNF-α, IL-1β, IL-6) in synovial tissue, improved local microcirculation. PBM doesn't cure structural joint disease but modulates pain and inflammation enough to meaningfully change function.

For knee OA specifically, near-infrared (810–850nm) penetration matters — the deeper wavelength reaches the joint capsule and synovial tissue. R1SE's bed delivers both wavelengths; positioning near affected joints is straightforward.

Posten et al. (2005, Dermatologic Surgery 31(3): 334-340) reviewed the LLLT wound-healing literature and reported a 40% acceleration in healing rates across the included trials — diabetic foot ulcers, venous leg ulcers, surgical wounds, burns.

Mechanism: fibroblast proliferation, collagen synthesis (same as the skin literature), angiogenesis via VEGF expression, modulated inflammatory phase of healing. The wound moves through the inflammation-to-proliferation transition faster and exits cleaner.

Clinical applications: post-surgical recovery, diabetic ulcer adjunctive care, burn recovery, oral mucositis from chemotherapy (Bjordal et al. 2011). R1SE doesn't treat active medical wounds — for those, see your GP or wound clinic. But the underlying mechanism is the same one supporting the skin and recovery effects we do deliver.

Brainard et al. (2001) and Lucas et al. (2014) established that the circadian system responds primarily to short-wavelength (blue) light — red light is essentially circadian-neutral. Pre-sleep red light exposure doesn't suppress melatonin the way evening screens or bright overhead light do.

Zhao et al. (2012, J Athl Train 47(6): 673-678) ran an RCT in elite female basketball players showing 14 days of evening red light improved Pittsburgh Sleep Quality Index scores and serum melatonin levels. Small trial but the effect size was meaningful.

Practical implication: red light sessions slot well into a sleep-supportive routine in ways bright overhead light cannot. Many R1SE members find evening sessions improve sleep onset and quality that night. R1SE's bundled session is comfortable enough that some members effectively use it as a pre-sleep wind-down ritual.

Weight loss / body contouring. Some marketing claims red light burns fat directly. The evidence here is weak. Local-fat-reduction trials exist but the magnitude is small and the mechanism (transient effects on adipocyte permeability) is not well-established for sustained weight loss. Don't book red light specifically to lose weight.

Cancer treatment. Red light has no established role in cancer treatment. Some marketing claims red light cures or prevents cancer — these are unsupported. (Specific PDT — photodynamic therapy — is a clinical cancer treatment, but that's a different modality using photosensitisers and different wavelengths.)

Vision improvement / restoration. Some emerging research on retinal mitochondrial function under specific protocols (Jeffery et al.) but the practical applications are not yet established. Don't expect vision changes from R1SE's bundled session.

Severe psychiatric conditions as standalone treatment. The depression evidence is emerging, not a replacement for medical care. Severe depression, bipolar disorder, schizophrenia — these need clinical management. Red light may be a credible adjunct; it's not a primary intervention.